Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Breast Neoplasms 379Neoplasms 336Carcinoma, Non-Small-Cell Lung 297Prostatic Neoplasms 250Colorectal Neoplasms 223Lung Neoplasms 195Multiple Myeloma 155Ovarian Neoplasms 142Pancreatic Neoplasms 140Neoplasm Metastasis 132Leukemia, Myeloid, Acute 129Melanoma 112Squamous Cell Carcinoma of Head and Neck 96Lymphoma 89Carcinoma, Renal Cell 89Stomach Neoplasms 87Recurrence 87Lymphoma, Non-Hodgkin 86Endometrial Neoplasms 85Brain Neoplasms 83Carcinoma, Hepatocellular 82Precursor Cell Lymphoblastic Leukemia-Lymphoma 81Head and Neck Neoplasms 73Glioma 73Glioblastoma 73Uterine Cervical Neoplasms 71Sarcoma 69Urinary Bladder Neoplasms 67Hematologic Neoplasms 66Leukemia, Lymphocytic, Chronic, B-Cell 65

Interventions

Watchful Waiting 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Neuroendocrine Tumors (pNET) × 30 days × Clear all
NCT07591493 2026-05-15

ADJUPANET

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Not yet recruiting
300 enrolled
EndocrineGastrointestinalNET

Pancreatic Neuroendocrine Tumors (pNET)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡